| Entry |
|
|---|
| Name |
Risedronic acid (INN);
Ridron (TN) |
|---|
| Formula |
C7H11NO7P2
|
|---|
| Exact mass |
283.0011
|
|---|
| Mol weight |
283.1123
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Musculo-skeletal system agent
DG03232 Osteoporosis agent
DG01600 Bisphosphonate
|
|---|
| Remark |
| Product (DG00786): | D00942<US> D03234<JP/US> D11570<US> |
|
|---|
| Efficacy |
Antiresorptive, Farnesylpyrophosphate synthetase inhibitor |
|---|
| Comment |
Bisphosphonate
|
|---|
| Target |
|
|---|
| Pathway |
| hsa00900 | Terpenoid backbone biosynthesis |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M05 DRUGS FOR TREATMENT OF BONE DISEASES
M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
M05BA Bisphosphonates
M05BA07 Risedronic acid
D08484 Risedronic acid (INN)
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG03232 Osteoporosis agent
DG01600 Bisphosphonate
DG00786 Risedronic acid
D08484 Risedronic acid
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Alkyl/Aryl transferases
FDPS
D08484 Risedronic acid (INN)
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG03232 Osteoporosis agent
DG01600 Bisphosphonate
DG00786 Risedronic acid
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 17
1 C1d C 23.2181 -23.8391
2 P1b P 24.3996 -24.5341
3 P1b P 22.0366 -24.5341
4 C1b C 23.2181 -22.5186
5 C8y C 24.3996 -21.8236
6 C8x C 25.5811 -22.5186
7 N5x N 26.7626 -21.8236
8 C8x C 26.7626 -20.4337
9 C8x C 25.5811 -19.7387
10 C8x C 24.3996 -20.4337
11 O1c O 20.8552 -23.8391
12 O1c O 22.0366 -25.9241
13 O1c O 20.5077 -25.5071
14 O1c O 25.5811 -23.8391
15 O1c O 24.3996 -25.9241
16 O1c O 25.5811 -25.2291
17 O1a O 23.2181 -25.2391
BOND 17
1 1 2 1
2 1 3 1
3 1 4 1
4 4 5 1
5 5 6 2
6 6 7 1
7 7 8 2
8 8 9 1
9 9 10 2
10 5 10 1
11 3 11 2
12 3 12 1
13 3 13 1
14 2 14 2
15 2 15 1
16 2 16 1
17 1 17 1
|
|---|
